Join
Live feed
·
PRReleasevia Quantisnow
Bristol-Myers Squibb Company logo
Atrium Therapeutics Inc. logo

Atrium Therapeutics Earns $15 Million Milestone Payment from Bristol Myers Squibb Under Global Cardiovascular Collaboration

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BMY (Bristol-Myers Squibb Company), RNA (Atrium Therapeutics Inc.) and more on Quantisnow.